Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study.

IF 5 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Journal of Clinical Endocrinology & Metabolism Pub Date : 2024-08-13 DOI:10.1210/clinem/dgae100
Guo-Chong Chen, Daniel Nyarko Hukportie, Yu-Jie Liu, Hai-Peng Wang, Li-Qiang Qin, Wei-Dong Fan, Fu-Rong Li, Xian-Bo Wu
{"title":"Microvascular Disease, Cardiovascular Health, and Risk of Coronary Heart Disease in Type 2 Diabetes: A UK Biobank Study.","authors":"Guo-Chong Chen, Daniel Nyarko Hukportie, Yu-Jie Liu, Hai-Peng Wang, Li-Qiang Qin, Wei-Dong Fan, Fu-Rong Li, Xian-Bo Wu","doi":"10.1210/clinem/dgae100","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>The interplay between cardiovascular health metrics (CVHMs) and microvascular disease (MVD) in relation to the risk of incident coronary heart disease (CHD) among individuals with type 2 diabetes mellitus (T2DM) remains to be evaluated.</p><p><strong>Objective: </strong>To investigate the role of MVD and CVHMs in the development of CHD among T2DM.</p><p><strong>Design: </strong>We included 19 664 participants with T2DM from the UK Biobank who had CVHM data and were free of CHD during recruitment. CVHMs were defined based on 5 behavioral (body mass index, diet, sleep duration, smoking, and regular exercise) and 3 biological (glycemic control, hyperlipidemia, and hypertension) factors. MVD was defined as the presence of retinopathy, peripheral neuropathy, or chronic kidney disease. Hazard ratio (HR) and 95% CI of CHD were estimated by multivariable Cox regression models.</p><p><strong>Results: </strong>There were 3252 incident cases of CHD recorded after a median follow-up of 12.3 years. After multivariable adjustment, each MVD was separately associated with risk of CHD, and those who had 1 or ≥ 2 MVD had a 27% and an 87% increased risk of developing CHD, respectively. Each unfavorable CVHM was associated with a higher risk of CHD. As compared with MVD-free participants who had ideal CVHMs, those who had ≥ 2 MVD and had poor CVHMs were at particularly high risk of incident CHD (HR = 4.58; 95% CI: 3.58, 5.86), similarly when considering behavioral CVH or biological CVH separately. On an additive scale, there was a positive statistically significant interaction between number of MVD and CVHMs.</p><p><strong>Conclusion: </strong>Coexistence of multiple MVDs was associated with a substantially higher risk of CHD among individuals with T2DM. Such association may be amplified by unfavorable CVHMs.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae100","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Context: The interplay between cardiovascular health metrics (CVHMs) and microvascular disease (MVD) in relation to the risk of incident coronary heart disease (CHD) among individuals with type 2 diabetes mellitus (T2DM) remains to be evaluated.

Objective: To investigate the role of MVD and CVHMs in the development of CHD among T2DM.

Design: We included 19 664 participants with T2DM from the UK Biobank who had CVHM data and were free of CHD during recruitment. CVHMs were defined based on 5 behavioral (body mass index, diet, sleep duration, smoking, and regular exercise) and 3 biological (glycemic control, hyperlipidemia, and hypertension) factors. MVD was defined as the presence of retinopathy, peripheral neuropathy, or chronic kidney disease. Hazard ratio (HR) and 95% CI of CHD were estimated by multivariable Cox regression models.

Results: There were 3252 incident cases of CHD recorded after a median follow-up of 12.3 years. After multivariable adjustment, each MVD was separately associated with risk of CHD, and those who had 1 or ≥ 2 MVD had a 27% and an 87% increased risk of developing CHD, respectively. Each unfavorable CVHM was associated with a higher risk of CHD. As compared with MVD-free participants who had ideal CVHMs, those who had ≥ 2 MVD and had poor CVHMs were at particularly high risk of incident CHD (HR = 4.58; 95% CI: 3.58, 5.86), similarly when considering behavioral CVH or biological CVH separately. On an additive scale, there was a positive statistically significant interaction between number of MVD and CVHMs.

Conclusion: Coexistence of multiple MVDs was associated with a substantially higher risk of CHD among individuals with T2DM. Such association may be amplified by unfavorable CVHMs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2 型糖尿病患者的微血管疾病、心血管健康和冠心病风险:英国生物库研究。
背景:心血管健康指标(CVHMs)和微血管疾病(MVD)与2型糖尿病(T2DM)患者冠心病(CHD)发病风险之间的相互作用仍有待评估:目的:研究微血管病变和冠状动脉高密度脂蛋白血症在 T2DM 患者冠心病发病中的作用:我们从英国生物库中纳入了 19,664 名患有 T2DM 的参与者,这些参与者在招募期间拥有 CVH 指标(CVHMs)数据且无冠心病。CVHMs的定义基于五个行为因素(体重指数、饮食、睡眠时间、吸烟和定期锻炼)和三个生物因素(血糖控制、高脂血症和高血压)。视网膜病变、周围神经病变和慢性肾脏病定义为 MVD。通过多变量考克斯回归模型估算了冠心病的 HR 和 95% CI:中位随访 12.3 年后,共记录了 3252 例冠心病病例。经多变量调整后,每种MVD都与冠心病风险相关,患有1种或≥2种MVD的患者患冠心病的风险分别增加了27%和87%。每种不利的心血管健康指标都与较高的冠心病风险相关。与具有理想 CVHMs 的无 MVD 参与者相比,具有≥2 MVD 和不良 CVHMs 的参与者发生冠心病的风险特别高(HR=4.58;95% CI:3.58,5.86),单独考虑行为 CVH 或生物 CVH 时也是如此。从加法的角度看,MVD和CVHMs的数量之间存在统计学意义上的正交互作用:结论:在 T2DM 患者中,同时存在多种 MVD 与更高的冠心病风险相关。结论:多发性血管病变并存与 T2DM 患者发生冠心病的风险大幅升高有关,而不利的 CVHMs 可能会放大这种关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Endocrinology & Metabolism 医学-内分泌学与代谢
CiteScore
11.40
自引率
5.20%
发文量
673
审稿时长
1 months
期刊介绍: The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
期刊最新文献
17α-hydroxylase/17,20-lyase deficiency (17-OHD): A Meta-analysis of Reported Cases. Clinical and radiological features of atypical adrenal masses- a multicenter retrospective study. Molecular and clinical profiles of pediatric monogenic diabetes subtypes: comprehensive genetic analysis of 138 patients. Anastrozole improves height outcomes in growing children with congenital adrenal hyperplasia due to 21-OHD. The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1